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Pat proteins regulate the transition of mRNAs from a state
that is translationally active to one that is repressed,
committing targeted mRNAs to degradation. Pat proteins
contain a conserved N-terminal sequence, a proline-rich
region, a Mid domain and a C-terminal domain (Pat-C). We
show that Pat-C is essential for the interaction with mRNA
decapping factors (i.e. DCP2, EDC4 and LSm1–7), whereas
the P-rich region and Mid domain have distinct functions
in modulating these interactions. DCP2 and EDC4 binding
is enhanced by the P-rich region and does not require
LSm1–7. LSm1–7 binding is assisted by the Mid domain
and is reduced by the P-rich region. Structural analysis
revealed that Pat-C folds into an a–a superhelix, exposing
conserved and basic residues on one side of the domain.
This conserved and basic surface is required for RNA,
DCP2, EDC4 and LSm1–7 binding. The multiplicity of
interactions mediated by Pat-C suggests that certain of
these interactions are mutually exclusive and, therefore,
that Pat proteins switch decapping partners allowing
transitions between sequential steps in the mRNA decap-
ping pathway.
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Introduction
Decapping of bulk mRNA in eukaryotes occurs after they
have been deadenylated. This order of events (deadenylation
ﬁrst, then decapping) ensures that functional, fully polyade-
nylated mRNAs are not decapped and degraded prematurely
(Bail and Kiledjian, 2006; Simon et al, 2006; Franks and
Lykke-Andersen, 2008). How decapping and deadenylation
are coordinated is, however, poorly understood. The yeast
protein Pat1 and its orthologs in Drosophila melanogaster
(HPat) and humans (PatL1) are conserved decapping activa-
tors that likely mediate this coordination by interacting both
with components of the CAF1-CCR4-NOT1 deadenylase com-
plex and with decapping factors (e.g. the DEAD-box protein
Me31B, the decapping enzyme DCP2 and the LSm1–7 ring;
Hatﬁeld et al, 1996; Bonnerot et al, 2000; Bouveret et al,
2000; Tharun et al, 2000; He and Parker, 2001; Tharun and
Parker, 2001; Chowdhury et al, 2007; Chowdhury and
Tharun, 2008, 2009; Tharun, 2009; Haas et al, 2010).
Pat proteins are characterized by a conserved N-terminal
sequence of about 50 residues (N-term) followed by a
proline-rich region (P-rich), a middle (Mid) domain, and
a C-terminal domain termed Pat-C (Figure 1A). Studies
in D. melanogaster showed that the HPat N-term sequence
confers binding to the DEAD-box protein Me31B
(Saccharomyces cerevisiae Dhh1 and human DDX6/RCK),
whereas the Mid domain is necessary and sufﬁcient for
LSm1–7 binding (Haas et al, 2010). Despite conservation,
the N-term sequence is not required to restore decapping in
cells depleted of endogenous HPat (Haas et al, 2010). In
contrast, the P-rich region together with the Mid domain
and Pat-C are all required to restore decapping in comple-
mentation assays (Haas et al, 2010). A somewhat different
picture has emerged from studies in S. cerevisiae where only
the Mid domain was shown to be essential for Pat1 function
in vivo (Pilkington and Parker, 2008). These differences raise
important and unresolved questions: what are the functions
of the Pat protein domains in decapping and to what extent
are these functions conserved?
In this study, we characterized PatL1, the human ortholog
of the Pat protein family. We found that PatL1 interacts with
DDX6/RCK, DCP2, EDC4 and the LSm1–7 ring. With the
exception of DDX6, these interactions require Pat-C.
Moreover, Pat-C is also critical for PatL1 to accumulate in
P-bodies and to be incorporated into active decapping com-
plexes. To shed light on the molecular basis for Pat-C func-
tions, we determined the Pat-C three-dimensional structure at
3.1A ˚ resolution. Pat-C adopts an a–a superhelical fold related
to armadillo- and huntigton-elongation-A-subunit-TOR
(HEAT)-repeat proteins. Using structure-based mutagenesis,
we show that both a basic surface patch and a partially
overlapping surface composed of highly conserved residues
have a critical function in the interaction with DCP2, EDC4
and the LSm1–7 ring. We further show that the conserved
surface of Pat-C is also essential for LSm1–7 binding in D.
melanogaster. Accordingly, a D. melanogaster HPat protein
carrying mutations in the conserved Pat-C surface cannot
rescue decapping in cells depleted of endogenous HPat. Our
results provide structural insight into Pat proteins and show
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Figure 1 PatL1 coimmunoprecipitates DDX6/RCK, LSm1, DCP2 and EDC4. (A) Pat proteins contain a conserved N-term sequence, a P-rich
region, a Mid domain and Pat-C. Amino-acid positions at fragment boundaries are indicated for human PatL1. Red box: conserved sequence
motif in the P-rich region. (B–I) GFP- and HA-tagged proteins were coexpressed in human cells as indicated. Cell lysates were immunopre-
cipitated using anti-GFP or anti-HA antibodies. GFP- or HA-tagged maltose binding protein (MBP) served as a negative control. In lanes 5–6 of
(B–E), cell lysates were treated with RNase A before immunoprecipitation. Inputs and immunoprecipitates were analysed by western blotting
using anti-GFP and anti-HA antibodies.
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mRNA decapping.
Results
PatL1 interacts with DDX6/RCK, DCP2, EDC4
and the LSm1–7 ring
To investigate the function of PatL1 in decapping, we ﬁrst
examined its association with decapping activators in human
embryonic kidney 293 cells (HEK293 cells). We observed that
epitope-tagged PatL1 coimmunoprecipitated DDX6/RCK,
DCP2, LSm1 and EDC4. These interactions were all insensi-
tive to RNase A treatment (Figure 1B–E). Together with
earlier studies, these results indicate that Pat proteins estab-
lish conserved interactions with DDX6/RCK, DCP2 and
the LSm1–7 ring, as these interactions are observed for the
orthologous proteins in human, D. melanogaster, and
S. cerevisiae cells (Figure 1B–D; Bonnerot et al, 2000;
Bouveret et al, 2000; Fromont-Racine et al, 2000; Tharun
et al, 2000; Coller et al, 2001; Tharun and Parker, 2001;
Fischer and Weis, 2002; Haas et al, 2010). In contrast, an
interaction between Pat proteins and EDC4 has not been
reported earlier. This interaction may only occur in metazoa,
because there is no EDC4 ortholog in yeast.
Pat-C is the only structured domain in Pat proteins
Pat proteins contain a conserved N-term sequence, the P-rich
region, the Mid domain and Pat-C (Figure 1A). Secondary
structure predictions suggest that PatL1 residues 1–398 (span-
ning the N-term sequence and the P-rich region) do not
contain a folded protein domain, consistent with the very
high content of proline residues (16.4%) and the low level of
sequence conservation in the P-rich region.
The two remaining domains (Mid: residues 399–516, and
Pat-C: residues 517–770) are well conserved and predicted to
be mainly a-helical (Supplementary Figure S1). Using multi-
angle static laser-light scattering coupled with size-exclusion
chromatography, we found that puriﬁed recombinant Pat-C is
monomeric in solution (Supplementary Table S1) and elutes
as expected for a well behaved, globular protein domain of
the respective mass (29kDa; Supplementary Table S1).
A protein fragment containing the Mid domain and Pat-C
(residues 399–770) was also monomeric in solution, but
eluted much earlier than expected for a globular protein
(apparent molecular mass of 75kDa as opposed to the
expected value of 42kDa (Supplementary Table S1)). These
results suggest the Mid domain is unstructured in this con-
text. Accordingly, even if the Mid domain was N-terminally
extended to include a conserved motif between residues 353
and 370 (Figure 1A, red box), it did not assume any second-
ary structure in solution, as determined by NMR analysis
(Supplementary Figure S2). Although these results do not
rule out the possibility that the Mid domain adopts the
predicted secondary structure only when bound to a protein
partner, they clearly indicate that Pat-C is the only domain in
PatL1 that folds independently as ultimately shown through
crystal structure analysis (see below).
PatL1 N-terminal sequence confers binding
to DDX6/RCK
In earlier studies, we showed that the N-term sequence of
D. melanogaster HPat confers binding to Me31B (Haas et al,
2010). Accordingly, for human PatL1 the conserved N-term
sequence was necessary and sufﬁcient for the interaction
with DDX6/RCK (Figure 1F). Two observations support this
conclusion: (1) deleting the N-term sequence abolished PatL1
interaction with DDX6/RCK (Figure 1F, lane 8) and (2) when
fused to GFP, the N-term sequence alone coimmunoprecipi-
tated DDX6/RCK as efﬁciently as full-length PatL1 (Figure 1F,
lane 7). Thus for PatL1, the ability to bind DDX6/RCK is
solely embedded in the conserved N-term sequence.
Pat-C is required for binding to DCP2, EDC4 and the
LSm1–7 ring
Next, we investigated which domains of PatL1 are required for
the interaction with DCP2, EDC4 and the LSm1–7 ring. We
observed that PatL1 interaction with LSm1 required both the
Mid domain and Pat-C (Figure 1G). Indeed, deleting these
domains either individually or in combination abolished
LSm1 binding (Figure 1G, lanes 8–10). In contrast, only Pat-
C, but not the Mid domain, was required for PatL1 to interact
with DCP2 and EDC4 (Figure 1H and I, lanes 9 and 10). An
important implication from these results is that DCP2 and EDC4
interact with PatL1 independently of the LSm1–7 ring. Indeed, a
PatL1 mutant lacking the Mid domain (DMid) no longer inter-
acts with the LSm1–7 ring but retains the ability to associate
with DCP2 and EDC4 (Figure 1G–I, lane 9). Furthermore, PatL1
interaction with LSm1, DCP2 or EDC4 was not affected by
deleting the N-term sequence (Supplementary Figure S3A–C),
indicating that these proteins associate with PatL1 indepen-
dently of DDX6/RCK. Of note, DCP2 and EDC4 interact with
each other (Fenger-Gr^n et al, 2005; Jı ´nek et al, 2008), and may
associate with PatL1 as a complex.
The Pat-C and P-rich regions cooperate to bind DCP2
and EDC4
To gain a precise understanding of the sequences in PatL1
important for DCP2 and EDC4 binding, we performed coim-
munoprecipitation assays with several PatL1 fragments. As
mentioned above, a PatL1 fragment containing the P-rich
region, the Mid domain and Pat-C (PatL1-DN-term) behaved
similar to wild type in binding DCP2 and EDC4
(Supplementary Figure S3A and B). In contrast, without the
P-rich region, the Mid domain and Pat-C showed lower
afﬁnity to EDC4 and did not bind DCP2 (Figure 2A and B,
lane 10). Thus, in addition to Pat-C, the P-rich region is also
required for binding EDC4 and DCP2. Accordingly, a protein
fragment containing the P-rich region and Pat-C was sufﬁ-
cient for binding to EDC4 and DCP2 (Figure 2A and B, lane
9). These results provide further evidence that EDC4 and
DCP2 binding does not require the Mid domain; and thus,
this interaction occurs independently of the LSm1–7 ring.
The Mid domain and Pat-C form a bipartite
LSm1-binding site
As shown in Figure 1G, deleting Pat-C abrogates LSm1
binding. This result contrasts with earlier studies showing
that the Mid domain is sufﬁcient for LSm1 binding both in
S. cerevisiae and D. melanogaster cells (Pilkington and Parker,
2008; Haas et al, 2010). Therefore, we investigated further, for
the human protein, the contribution of the Mid domain and
Pat-C in LSm1 binding. This analysis revealed two unex-
pected ﬁndings: (1) Pat-C, but not the Mid domain, was
sufﬁcient for LSm1 binding; although binding was reduced
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in several independent experiments, a fragment containing the
Mid domain and Pat-C coimmunoprecipitated LSm1 more
efﬁciently than wild-type PatL1 or PatL1-DN-term (Figure 2C,
lane 14; Supplementary Figure S3C); these ﬁndings suggest that
Pat-C and the Mid region cooperate to provide a high-afﬁnity
binding site for LSm1. Furthermore, PatL1 must contain se-
quences that interfere with LSm1 binding because the wild-type
protein binds LSm1 less efﬁciently than a fragment containing
the Mid domain and Pat-C. These interfering sequences are
located in the P-rich region, because a PatL1 mutant lacking the
N-term sequence also showed reduced LSm1 binding
(Figure 2C, lane 11). We conclude that the Mid domain and
Pat-C provide a bipartite binding site for LSm1–7, and that the
P-rich region interferes with this binding.
The P-rich region interferes with LSm1 binding
in D. melanogaster
The observations described above prompted us to re-investi-
gate the interaction between HPat and LSm1 in D. melano-
gaster, where we previously showed that the Mid domain was
sufﬁcient for LSm1 binding (Haas et al, 2010). As reported
before (Haas et al, 2010), we conﬁrmed that the Mid domain
alone, but not Pat-C, was sufﬁcient for LSm1 binding
(Figure 2D, lane 13 versus 14). When the Mid domain was
fused to Pat-C, the afﬁnity for LSm1 increased slightly,
suggesting that Pat-C contributes to the interaction
(Figure 2D, lane 12). In contrast, in mutants lacking Pat-C,
but containing the Mid domain and the P-rich region, the
interaction with LSm1 was abolished (DC and PþMid;
Figure 2D, lanes 10 and 11). We conclude that in D. melano-
gaster HPat, the Mid region confers binding to the LSm1–7
ring. This binding is enhanced by Pat-C and inhibited by the
P-rich region. The interfering effect of the P-rich region is
only observed in the absence of Pat-C, suggesting that Pat-C
counteracts the negative effect of the P-rich region. As
described above, the negative effect of the P-rich region is
less pronounced for human PatL1, most likely because the
major LSm1–7-binding site is provided by Pat-C and not by
the Mid domain.
Pat-C is required for PatL1 incorporation into active
decapping complexes
To investigate which domains of PatL1 are required for the
assembly of active decapping complexes, we performed
decapping assays in vitro. To this end, we immunoprecipi-
tated GFP-PatL1 (wild-type or deletion mutants) from
HEK293 cells and, using an m
7G-capped RNA substrate,
tested for decapping activity. Immunoprecipitated GFP-
PatL1 exhibited decapping activity (Figure 3A, lane 4),
whereas a PatL1 mutant lacking the Mid and Pat-C domains
did not copurify with decapping activity (Figure 3A, lane 5).
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Figure 2 Pat-C is required for binding to DCP2, EDC4 and LSm1–7. (A–C) GFP- and HA-tagged proteins were coexpressed in human cells as
indicated. Cell lysates were immunoprecipitated using anti-GFP or anti-HA antibodies and analysed as described in Figure 1. Numbers in italics
below the lanes in (A, B) represent coimmunoprecipitation efﬁciencies relative to wild-type PatL1. Values take into account differences in
protein expression levels in the inputs and the relative amount of PatL1 proteins in the immunoprecipitates. (D) HA-tagged wild-type HPat and
fragments were expressed in D. melanogaster S2 cells together with GFP-LSm1. Cell lysates were immunoprecipitated using anti-HA antibodies.
Asterisks indicate cross-reactivity of the primary antibodies with an endogenous protein (input panels).
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into active decapping complexes.
The decapping activity coimmunoprecipitating with PatL1
likely comes from the associated DCP2 (as a positive control,
compare an immunoprecipitation of GFP-DCP2; Figure 3A,
lane 3). Two observations support this conclusion: (1) if we
added nucleotide diphosphate kinase to the decapping reac-
tions containing either PatL1 or DCP2, then the m
7GDP
product was converted to m
7GTP (Figure 3A, lanes 8 and 9;
van Dijk et al, 2002; Fenger-Gr^n et al, 2005) and (2) a PatL1
mutant lacking Pat-C, which does not interact with DCP2, did
not copurify with decapping activity (Figure 3A, lane 7). In
contrast, a mutant carrying a deletion of the Mid domain,
which interacts with DCP2 but not with the LSm1–7 ring, was
impaired but could still coimmunoprecipitate decapping ac-
tivity (Figure 3A, lane 6). The amounts of PatL1 mutants in
the decapping assay were comparable to those of wild type
(Figure 3B). Thus, Pat-C is required for PatL1 association with
active decapping complexes.
Pat-C is required for P-body localization
S. cerevisiae Pat1 and its orthologs in metazoa localize to
P-bodies and are required for P-body integrity (Scheller et al,
2007; Eulalio et al, 2007a; Pilkington and Parker, 2008). To
deﬁne which domains are critical for human PatL1 to localize
to P-bodies, we examined the subcellular localization of
PatL1 fragments in human cells. GFP-PatL1 localized to
endogenous P-bodies (Figure 4A) as judged by the staining
with antibodies recognizing EDC4 (Kedersha and Anderson,
2007). A fragment of PatL1 comprising the N-term sequence
and P-rich region dispersed throughout the cytoplasm in 96%
of cells (Figure 4B). Moreover, 31% of the cells expressing
this fragment showed no detectable P-bodies, indicating this
protein fragment affects P-body integrity in a dominant-
negative manner. In contrast, a protein fragment comprising
the Mid domain and Pat-C retained the ability to localize to
P-bodies (16% of cells), although much less efﬁciently than
full-length PatL1 (Figure 4C versus 4A).
We next investigated whether the Mid domain or Pat-C are
required for PatL1 to localize to P-bodies. A PatL1 mutant
lacking the Mid domain was detected in P-bodies in 49% of
cells (Figure 4D), suggesting the Mid domain contributes, but
is not required for P-body localization. In contrast, a mutant
lacking Pat-C spread throughout the cytoplasm in 96% of
cells, although EDC4-contaning foci were detectable in 47%
of cells (Figure 4E). Together, these results indicate that
Pat-C has a critical function in promoting PatL1 accumulation
in P-bodies.
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Figure 3 Pat-C is required for PatL1 incorporation into active decapping complexes. (A–D) GFP-tagged proteins were expressed in human
cells. Cell lysates were immunoprecipitated using anti-GFPantibodies. The immunoprecipitates were tested for decapping activity using in vitro
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32P-labelled capped mRNA. Samples corresponding to (A, C) were analysed by western blotting in (B, D), respectively, to ensure
that equivalent amounts of proteins were present in the decapping assay.
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So far, our data indicate that Pat-C is required for binding to
DCP2, EDC4 and LSm1–7 and also enables PatL1 to localize
to P-bodies and be incorporated into active decapping com-
plexes. To gain a more detailed understanding of these
functions, we determined the crystal structure of Pat-C.
We obtained well-diffracting crystals of Pat-C (residues
517–767) and of Pat-C-Dloop (residues 517–767), where a
putative loop (residues 664–673) was replaced by a Gly-Ser
linker (Supplementary Figure S1B). Initially, the structure
was solved using single anomalous dispersion data (2.2A ˚
resolution) collected at the absorption peak of a seleno-
methionine-substituted protein crystal of Pat-C-Dloop. The
structure was automatically built starting from an excellent
multiple anomalous dispersion electron density map, and
was manually reﬁned to an Rwork of 19.9% (Rfree¼23.2%),
with two molecules per asymmetric unit (crystal form I;
Supplementary Table S2; Supplementary Figure S4A).
Subsequently, this model was used in molecular replace-
ment to solve the structure of Pat-C at 3.1A ˚ resolution, with
four molecules per asymmetric unit in a different packing
environment (Rwork¼24.8%, Rfree¼28.1%, crystal form II;
Supplementary Table S2 and Supplementary Figure S4A).
Finally, we obtained an unrelated crystal form of Pat-C-
Dloop at 2.95A ˚ resolution (Rwork¼24.8%, Rfree¼29.2%,
crystal form III; Supplementary Table S2). In this crystal
form, two of the three molecules in the asymmetric unit
apparently contain a speciﬁcally bound sulphate ion from the
crystallization condition, coordinated by two arginines
(Arg591 and Arg595; Supplementary Figure S4B). Sulphate
ions can mimic the phosphate groups of the nucleic acid
backbone and therefore indicate potential nucleic acid-bind-
ing sites (see below).
Pat-C folds into an a–a superhelix
Pat-C is composed of 13 a-helices, stacked into a superhelix
with a right-handed twist. The ﬁrst two helices are signiﬁ-
cantly longer than the others and form a hairpin that pro-
trudes B20A ˚ from the cylindrical core of the domain, giving
Pat-C an overall L-shape (Figure 5A–C).
According to the structural classiﬁcation of proteins
(SCOP; Murzin et al, 1995), the a–a superhelix fold (SCOP
classiﬁcation 48370) is a feature of 420 protein superfami-
lies. Among those, the structure of Pat-C clusters with mem-
bers of the ARM-repeat superfamily, as revealed by a search
using the Dali server (Holm and Sander, 1995). The ARM-
repeat superfamily includes families such as the armadillo-,
HEAT- and Pumilio-repeat families. The best-scoring structur-
al relatives of Pat-C thus include yeast Cse1 (Matsuura and
Stewart, 2004), human Pumilio1 (Wang et al, 2002) and
interestingly, the C-terminal domain of EDC4 (Jı ´nek et al,
2008).
Compared with canonical armadillo-, HEAT- or Pumilio-
repeat domains, however, the helical arrangement of Pat-C is
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Figure 4 Pat-C is required for PatL1 accumulation in P-bodies.
(A–H) Representative confocal ﬂuorescent micrographs of ﬁxed
human HeLa cells expressing wild-type GFP-PatL1 or the mutants
indicated on the left. Cells were stained with antibodies cross-
reacting with EDC4 and a nuclear human antigen (Kedersha and
Anderson, 2007). The merged images show the GFP signal in green
and the EDC4 signal in red. The fraction of cells exhibiting a
staining identical to that shown in the representative panel was
determined by scoring at least 100 cells in each of the three
independent transfections performed per protein. Scale bar: 10mm.
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consistently yielded Ca root mean square deviations (r.m.s.d.)
higher than 2.9A ˚. Only the ﬁrst nine helices (a1–a9) may be
classiﬁed as ARM-like repeats of three helices each.
Furthermore, Pat-C contains three large, partially ordered or
disordered loops that cluster on one face of the molecule.
These loops are located between helices a2 and a3
(L(a2–a3)), a8 and a9 (L(a8–a9)) and a10 and a11
(L(a10–a11); Figure 5A, back view; and Supplementary
Figure S4A).
Aligning the Pat-C sequence across different species shows
that key surface and structural residues are highly conserved.
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Figure 5 Structure of human Pat-C (Form II, chain A). (A) Ribbon diagram in two orientations related by a 1801 rotation along a vertical axis.
Loop L(a8–a9) is replaced by a Gly-Ser linker in Pat-C-D-loop construct. Structural representations were generated using Pymol (http://
www.pymol.org). (B) Surface representation, coloured by sequence conservation, comparing six species (Supplementary Figure S2B). Colour
ramp by identity: orange (100%) to white (0%). Highly conserved solvent exposed residues are labelled. (C) Electrostatic potentials are
mapped onto the molecular surface of Pat-C and contoured from  10kT/e
  (red) to 10kT/e
  (blue). Residues contributing to the positively
charged surface patch are labelled. (D) Ribbon representation of six Pat-C molecules resulting from the three independent crystal forms. Green
(Form I, chain A), dark blue (Form II, chain A), light blue (Form II, chain B), orange (Form III, chain A), red (Form III, chain B), yellow (Form
III, chain C). (E) Close-up view (401 rotated along a horizontal axis) on the helical protrusion of the six structurally most divergent Pat-C
molecules. Colours are as in (D). (F) Close-up on Form I, chain A, showing two water molecules buried in the helical protrusion. Residues
adjacent to the buried water molecules are labelled and shown as sticks with carbons in green, nitrogens in blue and oxygens in red. Hydrogen
bonds are shown as dashed lines.
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functions in all members of the Pat protein family
(Supplementary Figure S1B).
The helical protrusion of Pat-C exhibits structural
ﬂexibility
The three crystal forms of Pat-C provide nine independent
structures, in distinct molecular packing environments.
These nine structures superimpose well over the cylindrical
core of the domain with an r.m.s.d. of 0.58A ˚ (excluding loops
(L(a2–a3), L(a8–a9) and L(a10–a11); Figure 5D). The helical
protrusion, however, displays signiﬁcant structural variabil-
ity, especially near the tip of the hairpin (residues 539–557;
Figure 5D). The most extreme deviations are found in the
structures of crystal form III, with the distal parts of helix a2
(residues 550–558) being melted into an ordered loop
(Figure 5E, orange chain), or into an ordered loop with a
short b-strand (yellow), or into an entirely disordered loop
(red). One reason for this structural variability is likely the
hydrophilic nature of residues D535, R542 and D557.
Although being exposed to solvent in crystal form III, they
are also able to mediate close helix packing in crystal form I,
through two deeply buried water molecules (Figure 5F).
The structural variability of the helical protrusion
suggests a signiﬁcant ﬂexibility, which might be of functional
importance.
A basic surface on Pat-C confers binding to RNA
Proteins with an a–a superhelical fold frequently provide
scaffolds for protein or nucleic acid interactions (Huber et al,
1997; Edwards et al, 2001). In addition to be required for
protein–protein interactions, the Pat-C domain of yeast Pat1
shows afﬁnity for RNA (Pilkington and Parker, 2008). We
therefore looked for patches of conserved and/or basic
residues on the surface of Pat-C that might mediate the
observed interactions with decapping factors and/or with
RNA. The most highly conserved surface patch on Pat-C is
located near the N-terminal end of helix a1, close to the
connection to the Mid domain. It shares contributions from
Leu523, Glu527, Tyr530 and Leu534 on helix a1 as well as
contributions from Lys592 and Arg599 on helix a4
(Figure 5B).
The conserved patch partially overlaps with a region of
high positive surface potential (Figure 5C), which coordinates
the sulphate ion in crystal form III (Supplementary Figure
S4B) and results from a high concentration of positively
charged residues (Lys518, Arg519, Arg520, Lys521 on helix
a1, Arg591, Lys592, Arg595, Arg599 on helix a4 and Lys625,
Lys626 on helix a6). We therefore tested whether Pat-C could
bind RNA and found that it directly binds to an U30 RNA
oligomer in size exclusion chromatography experiments
(Supplementary Figure S5A).
In further experiments, we established that Pat-C exhibits
RNA-binding properties similar to those reported for the
puriﬁed yeast Pat1-LSm1–7 complex (Chowdhury et al,
2007). For instance, Pat-C interacted with oligo(rU)30 but
not with oligo(rA)30 (Supplementary Figure S5A and F).
Similarly, Chowdhury et al (2007) showed that yeast Pat1-
LSm1–7 complex interacts with oligo(rU) but not with any
other homo-oligoribonucleotide. Furthermore, Pat-C inter-
acted with a 30-nucleotide long homo(rU)-oligomer, but
failed to interact with oligomers containing 20 and 15 nucleo-
tides (Supplementary Figure S5A–C). Similarly, a require-
ment that RNA be a minimum length for detectable binding
was reported for the puriﬁed yeast Pat1-LSm1–7 complex
(Chowdhury et al, 2007), suggesting that some of the RNA-
binding properties of the complex can be attributed to Pat-C.
Finally, Pat-C discriminated between ribo- and deoxy-oligor-
ibonucleotides, as it did not interact with 20-deoxy-oligo(U)30
(Supplementary Figure S5F).
To investigate how much the Pat-C conserved and basic
patches contribute to RNA and protein binding, we generated
three mutants. In mutant 1 (Mut-1), six basic residues in the
positively charged patch were substituted with alanines
(R519, R520, R591, R595, K625 and K626; Supplementary
Figure S1B). In mutant 2 (Mut-2), four residues form the
conserved patch were changed into serine or alanine (L523S,
E527A, Y530A and L534S; Supplementary Figure S1B).
Finally, in mutant 3 (Mut-3), residues 539 to 557 were
substituted with a GSGSGSG linker (Supplementary Figure
S1B), thus excising the helical protrusion. When expressed,
puriﬁed and analysed by size exclusion chromatography, all
three Pat-C mutants showed the expected elution volumes for
folded monomeric proteins of the respective size
(Supplementary Table S1), indicating that the mutations do
not disrupt the Pat-C fold. Importantly, Mut-1 lost the ability
to bind U30 RNA, whereas Mut-2 was comparable to the wild-
type protein (Supplementary Figure S5D and E). Together,
these results indicate that the basic surface on the Pat-C
domain confers the ability to bind RNA.
The conserved and basic surfaces on Pat-C are required
for binding to DCP2/EDC4 and LSm1–7
We also investigated how the Pat-C conserved and basic
patches contribute to the interactions with decapping factors.
To this end, we introduced the mutations described above in
the context of full-length PatL1 and examined the effect on
DCP2, LSm1–7, and EDC4 binding, as well as on decapping
and P-body localization. We found that mutations in the basic
and conserved patches (Mut-1 and Mut-2) prevented
PatL1 from interacting with DCP2, EDC4 and the LSm1–7
ring as efﬁciently as deleting the Mid and Pat-C domains
(Figure 6A–C, lanes 9–11). In contrast, the mutations did not
affect the interaction with DDX6/RCK, as expected
(Figure 6D). Removing the helical protrusion (Mut-3) did
not affect the PatL1 interaction with DCP2 and decapping
activators (Figure 6A–C, lane 12).
To assess how the mutations affect PatL1 association with
decapping complexes, we tested the activity of the mutants in
decapping assays in vitro. In accordance with the results of
the coimmunoprecipitation assay, Mut-1 and Mut-2 failed to
copurify with decapping activity, whereas Mut-3 associated
with decapping activity (Figure 3C and D). Taken together,
these results show that the Pat-C conserved and basic patches
are crucial for the interaction with DCP2, EDC4 and the
LSm1–7 ring.
We next tested the ability of PatL1 mutants to localize to
P-bodies. We observed that Mut-1 and Mut-2 were dispersed
throughout the cytoplasm in about 90% of cells (Figure 4F
and G), whereas Mut-3 accumulates in foci (Figure 4H).
Furthermore, in about 60% of cells expressing Mut-1 or
Mut-2, endogenous P-bodies were dispersed (Figure 4F and
G), indicating that these mutants inhibit P-body formation in
a dominant-negative manner.
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decapping in vivo
To investigate how the Pat-C conserved surface inﬂuences
decapping in vivo, we took advantage of a complementation
assay established in D. melanogaster S2 cells (Haas et al,
2010). First, we mutated conserved residues in D. melano-
gaster HPat corresponding to Mut-2 in human PatL1
(Supplementary Figure S1B) and examined whether the
protein could coimmunoprecipitate LSm1 in S2 cells.
Similar to results obtained with human PatL1, we found
that mutating the conserved residues abrogates the interac-
tion with LSm1 as efﬁciently as deleting Pat-C entirely
(Figure 7A). Thus, the conserved surface on Pat-C is also
required for the interaction of D. melanogaster HPat with
LSm1–7.
Next, we investigated whether HPat Mut-2 could restore
decapping and mRNA degradation in cells depleted of en-
dogenous HPat (Haas et al, 2010). To monitor decapping, we
used the F-Luc-5BoxB reporter, which is rapidly degraded
when coexpressed with a lN fusion of the GW182 protein.
Indeed, lN-GW182 triggers deadenylation of the F-Luc-
5BoxB reporter, after which the mRNA is decapped and
then subjected to exonucleolytic digestion (Eulalio et al,
2007b). Inhibiting decapping prevents GW182-mediated
mRNA degradation and leads to the accumulation of
deadenylated mRNA decay intermediates, which exhibit a
characteristically higher electrophoretic mobility than poly-
adenylated transcripts (Figure 7B, lane 4 versus 2; Eulalio
et al, 2007b). Therefore, monitoring the accumulation
of the deadenylated F-Luc-5BoxB mRNA can track a block
in decapping.
S2 cells were transiently transfected with three plasmids:
the F-Luc-5BoxB reporter; a plasmid expressing lN-GW182
or the lN-peptide; and a transfection control plasmid, encod-
ing Renilla luciferase (R-Luc). In the presence of lN-GW182
we observed that, relative to cells expressing the lN-peptide
alone, the levels of the F-Luc-5BoxB mRNA were reduced
ﬁve-fold (Figure 7B, lane 2 versus 1 and Figure 7C). In
contrast, codepleting HPat and Me31B inhibited decapping
and allowed the deadenylated F-Luc-5BoxB mRNA to accu-
mulate (Figure 7B, lane 4 and Figure 7C).
Expressing HPat wild type in depleted cells restored de-
capping and degradation of F-Luc-5BoxB mRNA (Figure 7B,
lane 6 and Figure 7C). As reported before, the HPat mutant
lacking Pat-C was defective in promoting mRNA degradation,
indicating that Pat-C is required for decapping in vivo
(Figure 7B, lane 8; Haas et al, 2010). Importantly, HPat
Mut-2 was completely defective in restoring decapping and
therefore the deadenylated mRNA was still detectable
(Figure 7B, lane 10 and Figure 7C). All proteins were ex-
pressed at comparable levels (Figure 7D). We conclude that
the conserved surface on Pat-C is essential for HPat to
promote mRNA decapping in vivo.
Discussion
In this study, we determined the structure of PatL1 C-terminal
domain (Pat-C), the only domain in Pat proteins that folds
independently. Pat-C folds into an a–a superhelix, exposing
basic and conserved residues on one side of this domain. Our
functional and structural analysis of Pat-C identiﬁed several
critical and distinct functions for this protein domain: (1) it
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it cooperates with the P-rich region to provide a binding
surface for DCP2 and EDC4; (3) it cooperates with the
Mid domain to provide a high-afﬁnity interaction with the
LSm1–7 ring; (4) it is required for PatL1 to accumulate in
P-bodies and (5) it is essential for mRNA decapping in vivo.
The multiplicity of interactions mediated by Pat-C suggests
that these interactions might be synergistic or antagonistic
and thus may have a regulatory function as discussed below.
PatL1 interacts with DCP2 and multiple decapping
activators
In this article, we show the PatL1 N-term sequence confers
binding to DDX6/RCK. This interaction is conserved in
D. melanogaster where we showed that the HPat N-term
sequence also interacts with Me31B (Haas et al, 2010). We
further show the P-rich region and Pat-C both contribute to
the interaction with DCP2 and EDC4, whereas LSm1–7 bind-
ing requires the Mid domain and Pat-C (Figures 2 and 8).
From our studies, we cannot conclude whether PatL1 inter-
acts with decapping activators and DCP2 directly.
Nevertheless, our results allow us to draw several conclu-
sions. First, DCP2, EDC4 and the LSm1–7 ring interact with
PatL1 independently of the conserved N-term sequence, and
thus independently of DDX6/RCK. Second, EDC4 and DCP2
interact with PatL1 independently of the LSm1–7 ring, be-
cause deleting the Mid domain abolishes LSm1–7 binding but
not DCP2 or EDC4 binding. Third, LSm1–7 binding anti-
correlates with the binding of EDC4/DCP2, because, if the
P-rich region is fused to a protein fragment containing the
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creases, but binding to DCP2 and EDC4 is stimulated. Finally,
binding to DCP2, EDC4 and LSm1–7 is unlikely to be entirely
mediated by RNA because mutations in conserved Pat-C
surface residues do not affect RNA binding but abolish the
interaction with decapping factors. On the other hand, muta-
tions in the positive Pat-C surface abolish the interaction both
with RNA and with decapping factors, suggesting that RNA
may contribute to the afﬁnity of PatL1 for decapping factors.
The function of Pat-C in mRNA decapping
In this study, we show that Pat-C is required for D. melano-
gaster and human Pat proteins to interact with the LSm1–7
ring. Whether this is also true for yeast has not been directly
investigated; however, indirect evidence suggests that Pat-C
might also be important for LSm1 binding in yeast. Indeed,
Pilkington and Parker (2008) reported that the accumulation
of LSm1 in P-bodies depends on Pat1, and that LSm1 interacts
with the Pat1 Mid domain. Accordingly, it is intriguing that
Pat-C is necessary and sufﬁcient to promote LSm1 accumula-
tion in P-bodies (Pilkington and Parker, 2008). Our results
provide an explanation for this, in that although the isolated
Mid domain is sufﬁcient for LSm1 binding, Pat-C is also
required in the context of full-length Pat proteins and may
provide a low-afﬁnity LSm1-binding site.
Nevertheless, studies in S. cerevisiae indicated that for Pat1
function in vivo Pat-C is dispensable; whereas our studies
suggest, in D. melanogaster and human cells, this domain is
essential (Pilkington and Parker, 2008; Haas et al, 2010). One
possible explanation for resolving the discrepancy between
S. cerevisiae and metazoa lies in the realization that the
precise composition and stoichiometry of decapping
complexes differs signiﬁcantly between these organisms as
for example, yeast lacks an EDC4 ortholog. Thus, it is possible
that for metazoa, Pat-C is essential in decapping because it
interacts with EDC4 and DCP2. Yeast Pat1 interacts with DCP2
but this interaction is mediated by RNA (Tharun and Parker,
2001). The essential function of Pat-C may therefore reﬂect
additional functions this domain acquired in metazoa.
Does Pat switch decapping partners?
An unexpected observation from our studies is that Pat-C, but
not the Mid domain is sufﬁcient for LSm1 binding in human
cells, whereas in yeast and D. melanogaster cells, the Mid
domain but not Pat-C is sufﬁcient (Pilkington and Parker,
2008; Haas et al, 2010). Our hypothesis to explain these
results is that Pat proteins contain two distinct LSm1-binding
sites: one in the Mid domain and one in Pat-C. Human PatL1
interacts with LSm1 predominantly through Pat-C; whereas
in D. melanogaster and S. cerevisiae, the interaction through
the Mid domain dominates. However, for LSm1 binding, even
when the interaction with the Mid domain dominates, there is
a general requirement for Pat-C in the context of full-length
Pat. Indeed, in addition to enhance LSm1 binding by the Mid
domain, Pat-C is required to counteract a negative effect of
the P-rich region. Of note, the N-terminal boundary of the
Mid domain is difﬁcult to deﬁne and this may contribute to
the differences observed between species.
The requirement of Pat-C for LSm1–7 binding raises
the question of whether the LSm1–7 ring competes with
DCP2/EDC4 for binding to Pat-C. Two lines of evidence
support this scenario: (1) as mentioned above, we observed
that DCP2/EDC4- and LSm1 binding anti-correlate and (2) it
is unlikely that the small conserved patch on Pat-C can bind
to DCP2/EDC4 and the LSm1–7 ring simultaneously.
Competition between DCP2/EDC4 and LSm1–7 for Pat
binding would also help to explain the negative effects of
the P-rich region on the interaction with LSm1–7, because the
P-rich region enhances the afﬁnity of DCP2/EDC4 for PatL1.
Furthermore, there may be some residual afﬁnity of DCP2/
EDC4 for the P-rich region even in the absence of Pat-C. In
this case, DCP2/EDC4 could sterically mask the access of the
LSm1–7 ring to the Mid domain.
Alternatively, the negative effect of the P-rich region on
LSm1–7 binding could be a direct one, for example by
occluding the LSm1–7 binding site on the Mid domain.
However, it is difﬁcult to conceive how two unstructured
protein regions could interact with each other speciﬁcally.
Consistently, we could not detect an interaction in trans
between the P-rich region and the Mid domain. A third
explanation could be that additional interacting partners
bind to the P-rich region and regulate the accessibility of
the Mid domain (Figure 8, factor X). Although proteins
binding to the P-rich region have not yet been identiﬁed, it
is likely that this region interacts with additional components
of the decay machinery, because in D. melanogaster the
P-rich region was sufﬁcient to trigger degradation of
mRNAs in tethering assays (Haas et al, 2010).
Regardless of precisely how the P-rich region inhibits the
Mid domain from binding LSm1, our results suggest this
binding could be regulated, and that Pat proteins might
adopt two different conformations one with and the other
without afﬁnity for LSm1–7 (Figure 8). It remains to be
established whether these conformations represent distinct
complexes with speciﬁc functions or sequential steps in the
assembly of active decapping complexes on target mRNAs.
More generally, our ﬁndings challenge the notion that Pat
proteins act as simple scaffolds for the simultaneous assem-
bly of decapping factors and rather suggest that certain
of the interactions between decapping factors may occur
sequentially allowing decapping complexes to assemble in a
stepwise manner.
Materials and methods
Protein expression, puriﬁcation and crystallization
Human PatL1 proteins were expressed with an N-terminal His6-tag
in the Escherichia coli strain BL21 (DE3) or BL21 Star (DE3;
Invitrogen) at 251C overnight. After puriﬁcation by an Ni
2þ-afﬁnity
step (HiTrap Chelating HP column, GE Healthcare), the His6-tag was
cleaved with PreScission protease. The proteins were further
puriﬁed by ion exchange chromatography and gel ﬁltration (HiTrap
SP HP and HiLoad 26/60 Superdex 75 columns, GE Healthcare).
A detailed description of the crystallization procedures is provided
in the Supplementary data.
Structure determination and reﬁnement
Diffraction data were collected on beamline X10SA of the Swiss
Light Source, Villigen, Switzerland. The structure of the human
PatL1 fragment, Pat-C-Dloop (Form I), was determined from
multiple-wavelength anomalous dispersion data, collected on a
crystal of selenomethionine-substituted protein. For Pat-C (Form II)
and Pat-C-Dloop with bound sulphate (Form III), the structures
were solved by molecular replacement using Pat-C-Dloop (Form I)
as search model. Additional information is provided in the
Supplementary data.
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Plasmids for expressing DCP2, DDX6/RCK and EDC4 in human cells
were described before (Tritschler et al, 2009a,b). Plasmids for
expressing PatL1 were generated by cloning the corresponding
cDNA into the pEGFP-C1 vector (Clontech) or the plN-HA-C1
vector (Tritschler et al, 2009a,b). Human LSm1 was cloned between
the XhoI and EcoR1 sites of the plN-HA-C1 vector. PatL1 mutants
were generated by site-directed mutagenesis using the QuickChange
mutagenesis kit from Stratagene and the appropriate oligonucleo-
tide sequences.
Coimmunoprecipitation assays, western blotting
and ﬂuorescence microscopy
For coimmunoprecipitation assays, HEK-293 cells were grown in
10cm plates and transfected using Lipofectamine 2000 (Invitrogen).
The transfection mixtures contained 7mg of the GFP and HA
constructs. For ﬂuorescence microscopy, human HeLa cells were
grown on coverslips in 24-well plates and transfected using
Lipofectamine 2000 (Invitrogen). The transfection mixtures con-
tained 0.3mg of plasmids expressing GFP-protein fusions. Cells were
collected 2 days after transfection. Coimmunoprecipitations, wes-
tern blotting and ﬂuorescence microscopy were performed as
described earlier (Tritschler et al, 2009b). Additional information is
provided in the Supplementary data.
Decapping assays
Decapping assays were performed as described earlier (Lykke-
Andersen, 2002; Tritschler et al, 2009b), using an in vitro
synthesized RNA (127 nucleotides). The RNA probe was labelled
with [a-
32P]GTP using the ScriptCap m
7G Capping System and the
ScriptCap 20-O-Methyltransferase kit (EPICENTRE Biotechnologies).
Reactions were stopped by adding up to 50mM EDTA and analysed
on PEI cellulose thin-layer chromatography plates (Merck) in
0.75M LiCl (1ml/sample). Unlabelled GDP, m
7GMP, m
7GDP and
m
7GTP were used as markers.
Immunoprecipitations, RNA interference and
complementation assay in D. melanogaster S2 cells
Protein coimmunoprecipitations and complementation in S2 cells
were performed as described earlier (Haas et al, 2010). Mutants of
D. melanogaster HPat were generated by site-directed mutagenesis
using the plasmid pAc5.1B-HA-HPat (dsRNA resistant) as template,
and the QuickChange mutagenesis kit from Stratagene. Transfec-
tions of S2 cells were performed in six-well plates, using Effectene
transfection reagent (Qiagen). Fireﬂy and Renilla luciferase
activities were measured 3 days after transfection using the Dual-
Luciferase Reporter Assay System (Promega). Total RNA was
isolated using TriFast (Peqlab Biotechnologies) and analysed as
described earlier (Haas et al, 2010).
Coordinate deposition
Coordinates of the human PatL1 C-terminal domain constructs Pat-
C-Dloop (Form I), Pat-C (Form II) and Pat-C-Dloop with bound
sulphate (Form III) have been deposited in the Protein Data Bank
under accession numbers 2xes, 2xeq and 2xer, respectively.
Supplementary data
Supplementary data are available at The EMBO Journal Online
(http://www.embojournal.org).
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